LaSara Medical Group Review
Best for: patients in southern California who want hybrid in-person + telehealth access, or patients seeking a one-stop hormone-and-GLP-1 clinic and willing to confirm pricing + state coverage during the free consultation
LaSara Medical Group (lasara.com) is a national telehealth provider with in-person availability in southern California, offering compounded GLP-1s (semaglutide, tirzepatide) alongside a broader HRT and peptide menu (testosterone cypionate, NAD+, sermorelin, B12, enclomiphene). The intake flow includes a free consultation, medical form, and doctor approval. Pricing tables, partner pharmacy names, LegitScript status, and per-state availability are not disclosed on the marketing home page; gated behind the intake.
Medium confidence · Last verified 2026-05-09 via manual · How we verify provider data
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
LaSara Medical Group is a solid telehealth option with balanced features and pricing.
Score Breakdown
Drugs Offered
LaSara Medical Group prescribes the following GLP-1 medications. Tap a drug to read our clinical guide with FDA label info, dosing schedules, side effects, and trial data.
✓ Pros
- •Multi-modality clinic — compounded GLP-1s alongside TRT, peptides, B12, NAD+, sermorelin, enclomiphene (broader than most pure GLP-1 telehealth platforms)
- •Telehealth nationally + brick-and-mortar in-person option in southern California — uncommon hybrid model
- •Free initial consultation disclosed publicly
- •Active promotional pricing (30% off sitewide with code Memorial26 at the time of verification)
✗ Cons
- •Steady-state monthly pricing for compounded semaglutide and tirzepatide NOT disclosed publicly — gated behind intake
- •Specific legal entity name + state of incorporation NOT disclosed
- •Partner compounding pharmacy NOT disclosed
- •LegitScript certification status NOT confirmed on the home page
- •Per-state availability NOT enumerated despite the 'national telehealth' claim
- •Brand-name GLP-1 lineup (Wegovy/Zepbound/Mounjaro/Ozempic/Foundayo) NOT addressed on the marketing home
- •Multi-modality menu (TRT + peptides + GLP-1) raises the bar for medical oversight; lab work + ongoing monitoring inclusion NOT clearly disclosed in marketing copy
Ready to start with LaSara Medical Group?
See current pricing and start your free consultation.
Sources & methodology
Our LaSara Medical Group review applies the same 6-dimension scoring framework we use for every provider. Pricing, FDA approval status, compounding rules, and clinical-trial efficacy claims are sourced from the primary regulatory and peer-reviewed literature below.
Sources & methodology — as of May 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
Alternatives to LaSara Medical Group
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Frequently Asked Questions
Glossary references
Key terms in this article, linked to their canonical definitions.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Ready to start with LaSara Medical Group?
See current pricing and start your free consultation.